Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation?
Zoulim
Fabien
F
D003363:Cost Control; D016527:Drug Costs; D006509:Hepatitis B / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D007136:Immunoglobulins / Q000191:economics / Q000627:therapeutic use; D019259:Lamivudine / Q000191:economics / Q000627:therapeutic use; D016031:Liver Transplantation; D011182:Postoperative Care / Q000191:economics*; D011315:Preventive Medicine / Q000191:economics / Q000592:standards; D018894:Reverse Transcriptase Inhibitors / Q000191:economics / Q000627:therapeutic use; D055502:Secondary Prevention
D007136:Immunoglobulins; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; C045213:hepatitis B hyperimmune globulin